YBEY
gene geneOn this page
Summary
YBEY (ybeY metalloendoribonuclease, HGNC:1299) is a protein-coding gene on chromosome 21q22.3, encoding Endoribonuclease YbeY (P58557). Single strand-specific metallo-endoribonuclease involved in rRNA maturation.
This gene encodes a highly conserved metalloprotein. A similar protein in bacteria acts as an endoribonuclease, and is thought to function in ribosomal RNA maturation and ribosome assembly. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 54059 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 32 total
- MANE Select transcript:
NM_001314025
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:1299 |
| Approved symbol | YBEY |
| Name | ybeY metalloendoribonuclease |
| Location | 21q22.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000182362 |
| Ensembl biotype | protein_coding |
| OMIM | 617461 |
| Entrez | 54059 |
Gene structure
Transcript identifiers
Ensembl transcripts: 24 — 22 protein_coding, 2 retained_intron
ENST00000329319, ENST00000339195, ENST00000397691, ENST00000397692, ENST00000397694, ENST00000397701, ENST00000468924, ENST00000492864, ENST00000903442, ENST00000903443, ENST00000903444, ENST00000921775, ENST00000921776, ENST00000921777, ENST00000921778, ENST00000921779, ENST00000921780, ENST00000921781, ENST00000921782, ENST00000921783, ENST00000921784, ENST00000921785, ENST00000921786, ENST00000949821
RefSeq mRNA: 7 — MANE Select: NM_001314025
NM_001006114, NM_001314022, NM_001314023, NM_001314024, NM_001314025, NM_001314026, NM_058181
CCDS: CCDS33591, CCDS82685, CCDS82686, CCDS82687
Canonical transcript exons
ENST00000397701 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001302401 | 46291334 | 46291462 |
| ENSE00001322578 | 46296162 | 46296230 |
| ENSE00001529749 | 46297539 | 46297751 |
| ENSE00001820637 | 46286342 | 46286415 |
| ENSE00003566287 | 46286870 | 46287123 |
Expression profiles
Bgee: expression breadth ubiquitous, 254 present calls, max score 95.98.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.7270 / max 370.8697, expressed in 1803 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 189702 | 12.0004 | 1795 |
| 189704 | 1.9957 | 1187 |
| 189703 | 1.0971 | 543 |
| 189700 | 0.6046 | 326 |
| 189701 | 0.0292 | 3 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 95.98 | gold quality |
| right testis | UBERON:0004534 | 95.51 | gold quality |
| testis | UBERON:0000473 | 94.76 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 92.49 | silver quality |
| left ventricle myocardium | UBERON:0006566 | 92.31 | gold quality |
| sperm | CL:0000019 | 92.10 | gold quality |
| kidney epithelium | UBERON:0004819 | 90.46 | silver quality |
| caput epididymis | UBERON:0004358 | 90.10 | gold quality |
| corpus epididymis | UBERON:0004359 | 89.31 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 89.27 | gold quality |
| spinal cord | UBERON:0002240 | 88.85 | gold quality |
| islet of Langerhans | UBERON:0000006 | 88.83 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 88.51 | gold quality |
| pons | UBERON:0000988 | 88.28 | gold quality |
| tibialis anterior | UBERON:0001385 | 87.90 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 87.70 | gold quality |
| myocardium | UBERON:0002349 | 87.32 | silver quality |
| granulocyte | CL:0000094 | 87.14 | gold quality |
| body of tongue | UBERON:0011876 | 87.11 | gold quality |
| adult organism | UBERON:0007023 | 87.10 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 86.96 | gold quality |
| ileal mucosa | UBERON:0000331 | 86.91 | gold quality |
| upper arm skin | UBERON:0004263 | 86.77 | silver quality |
| subthalamic nucleus | UBERON:0001906 | 86.69 | gold quality |
| cauda epididymis | UBERON:0004360 | 86.59 | gold quality |
| monocyte | CL:0000576 | 86.42 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.40 | gold quality |
| leukocyte | CL:0000738 | 86.40 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 86.37 | gold quality |
| hypothalamus | UBERON:0001898 | 85.84 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.34 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): AP1, ZGPAT, ZNF91
miRNA regulators (miRDB)
6 targeting YBEY, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-12124 | 99.68 | 69.17 | 2700 |
| HSA-MIR-6887-3P | 99.66 | 67.83 | 1778 |
| HSA-MIR-6826-3P | 98.19 | 66.32 | 1153 |
| HSA-MIR-1298-5P | 95.96 | 64.81 | 573 |
| HSA-MIR-6795-3P | 91.86 | 63.00 | 218 |
Literature-anchored findings (GeneRIF, showing 4)
- This observation suggests that the function of HuYbeY in human cells is likely regulated through specific interactions with partner proteins similarly to the way YbeY is regulated in bacteria. (PMID:28153719)
- YBEY is an essential biogenesis factor for mitochondrial ribosomes. (PMID:32182356)
- YbeY, eminence grise of ribosome biogenesis. (PMID:33929506)
- YbeY is required for ribosome small subunit assembly and tRNA processing in human mitochondria. (PMID:34037799)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ybey | ENSDARG00000011999 |
| ENSDARG00000110510 | ||
| mus_musculus | Ybey | ENSMUSG00000033126 |
| rattus_norvegicus | Ybey | ENSRNOG00000021365 |
| drosophila_melanogaster | Brd7-9 | FBGN0031947 |
| caenorhabditis_elegans | swsn-9 | WBGENE00007256 |
Paralogs (2): BRD9 (ENSG00000028310), BRD7 (ENSG00000166164)
Protein
Protein identifiers
Endoribonuclease YbeY — P58557 (reviewed: P58557)
All UniProt accessions (1): P58557
UniProt curated annotations — full annotation on UniProt →
Function. Single strand-specific metallo-endoribonuclease involved in rRNA maturation.
Subcellular location. Nucleus.
Cofactor. Binds 1 zinc ion.
Miscellaneous. A protein of the expected size has been detected by antibody binding and Western blot in at least one of the analyzed tissues or cells.
Similarity. Belongs to the endoribonuclease YbeY family.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P58557-1 | A | yes |
| P58557-2 | B | |
| P58557-3 | C | |
| P58557-4 | D |
RefSeq proteins (5): NP_001300951, NP_001300952, NP_001300953, NP_001300954, NP_478061 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002036 | YbeY | Family |
| IPR020549 | YbeY_CS | Conserved_site |
| IPR023091 | MetalPrtase_cat_dom_sf_prd | Homologous_superfamily |
Pfam: PF02130
UniProt features (10 total): binding site 3, splice variant 3, mutagenesis site 3, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P58557-F1 | 96.39 | 0.97 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (3): 118; 122; 128
Mutagenesis-validated functional residues (3):
| Position | Phenotype |
|---|---|
| 55 | no endonuclease activity. |
| 90 | no endonuclease activity. |
| 118 | no endonuclease activity. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 68 (showing top):
GOBP_RIBOSOME_BIOGENESIS, GOMF_ENDONUCLEASE_ACTIVITY, GOMF_RNA_NUCLEASE_ACTIVITY, GOMF_METALLOPEPTIDASE_ACTIVITY, GOMF_NUCLEASE_ACTIVITY, GOMF_RNA_ENDONUCLEASE_ACTIVITY, chr21q22, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, GOMF_PEPTIDASE_ACTIVITY, GOMF_CATALYTIC_ACTIVITY_ACTING_ON_RNA, ALKBH3_TARGET_GENES, ELF2_TARGET_GENES, ID2_TARGET_GENES, KAT2A_TARGET_GENES, PCGF1_TARGET_GENES
GO Biological Process (1): rRNA processing (GO:0006364)
GO Molecular Function (7): metalloendopeptidase activity (GO:0004222), RNA endonuclease activity (GO:0004521), metal ion binding (GO:0046872), nuclease activity (GO:0004518), endonuclease activity (GO:0004519), protein binding (GO:0005515), hydrolase activity (GO:0016787)
GO Cellular Component (2): nucleus (GO:0005634), mitochondrion (GO:0005739)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular membrane-bounded organelle | 2 |
| RNA processing | 1 |
| rRNA metabolic process | 1 |
| ribosome biogenesis | 1 |
| endopeptidase activity | 1 |
| metallopeptidase activity | 1 |
| endonuclease activity | 1 |
| RNA nuclease activity | 1 |
| cation binding | 1 |
| catalytic activity, acting on a nucleic acid | 1 |
| nuclease activity | 1 |
| binding | 1 |
| catalytic activity | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
1859 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| YBEY | PNPT1 | Q8TCS8 | 713 |
| YBEY | RWDD2B | P57060 | 631 |
| YBEY | PCBP3 | P57721 | 610 |
| YBEY | RGP1 | Q92546 | 605 |
| YBEY | C21orf58 | P58505 | 577 |
| YBEY | ERAL1 | O75616 | 575 |
| YBEY | POFUT2 | Q9Y2G5 | 575 |
| YBEY | ELAC2 | Q9BQ52 | 545 |
| YBEY | REXO2 | Q9Y3B8 | 543 |
| YBEY | MCM3AP | O60318 | 542 |
| YBEY | RPS14 | P06366 | 513 |
| YBEY | CUTC | Q9NTM9 | 509 |
| YBEY | LACTB2 | Q53H82 | 502 |
| YBEY | MRPS6 | P82932 | 501 |
| YBEY | MRPL36 | Q9P0J6 | 497 |
IntAct
25 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DSN1 | ZWINT | psi-mi:“MI:0914”(association) | 0.900 |
| MIS12 | ZWINT | psi-mi:“MI:0914”(association) | 0.900 |
| YBEY | BCAT2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| RPS2 | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.530 |
| CBX5 | WIZ | psi-mi:“MI:0914”(association) | 0.530 |
| L3MBTL1 | DNAJB6 | psi-mi:“MI:0914”(association) | 0.530 |
| YBEY | NME4 | psi-mi:“MI:0914”(association) | 0.530 |
| YBEY | AKTIP | psi-mi:“MI:0915”(physical association) | 0.370 |
| YBEY | NUDT19 | psi-mi:“MI:0914”(association) | 0.350 |
| SSH3 | HSPA8 | psi-mi:“MI:0914”(association) | 0.350 |
| HAUS2 | FLNB | psi-mi:“MI:0914”(association) | 0.350 |
| L3MBTL4 | GAPDHS | psi-mi:“MI:0914”(association) | 0.350 |
| TUBGCP4 | SPTLC1 | psi-mi:“MI:0914”(association) | 0.350 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| CARTPT | MEIS1 | psi-mi:“MI:0914”(association) | 0.350 |
| GAS2L2 | ANKRD17 | psi-mi:“MI:0914”(association) | 0.350 |
| NUBP1 | YBEY | psi-mi:“MI:0914”(association) | 0.350 |
| CARTPT | LAMC1 | psi-mi:“MI:0914”(association) | 0.350 |
| KRT33B | EPPK1 | psi-mi:“MI:0914”(association) | 0.350 |
| Smad6 | DDX1 | psi-mi:“MI:0914”(association) | 0.350 |
| TBKBP1 | psi-mi:“MI:0914”(association) | 0.350 | |
| YBEY | GEM | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (141): YBEY (Affinity Capture-MS), YBEY (Affinity Capture-MS), YBEY (Affinity Capture-MS), YBEY (Affinity Capture-MS), YBEY (Affinity Capture-MS), YBEY (Affinity Capture-MS), YBEY (Affinity Capture-MS), YBEY (Affinity Capture-MS), YBEY (Affinity Capture-MS), YBEY (Affinity Capture-MS), YBEY (Affinity Capture-MS), BCAT2 (Affinity Capture-MS), GTPBP8 (Affinity Capture-MS), TRMU (Affinity Capture-MS), GFM2 (Affinity Capture-MS)
ESM2 similar proteins: A2VE14, B1H1Z8, B1WC68, B4ZIX8, O43913, O54865, O75648, P16068, P20595, P52848, P58557, Q02153, Q02353, Q0VCB2, Q0VCJ8, Q13635, Q1M199, Q3SZB3, Q3U129, Q3UHN9, Q3ZCQ8, Q4R4U1, Q4ZHR9, Q5E9U9, Q5NVN7, Q5R5F8, Q5ZMH6, Q61115, Q6AXQ0, Q6AYR2, Q7Z6J6, Q8BTG7, Q8CAV0, Q8VH37, Q8WTW4, Q91YQ7, Q923S8, Q96G75, Q9BY41, Q9CQC8
Diamond homologs: A0RIS3, A1QYL0, A1UU41, A3DEC2, A3PAQ0, A4IR19, A4J7D9, A4XKI9, A5IT98, A6Q9R0, A6QHB3, A6TSK3, A6U242, A6WWX4, A7GSZ7, A7X2W8, A7Z6U6, A8FFB6, A8IG05, A8MG66, A8Z4A9, A9IMW1, A9KMV9, A9M9Y5, A9NGT0, A9VHT0, B0CK02, B0K706, B0KA56, B1HTJ4, B7HCS7, B7HPK2, B7IYF4, B7J0Z6, B7JN28, B8DE46, B8FUL3, B9DNL6, B9E6W1, B9IY70
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
32 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 21 |
| Likely benign | 2 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
892 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:46286975:G:GG | donor_gain | 1.0000 |
| 21:46286985:GATT:G | donor_gain | 1.0000 |
| 21:46286994:G:GT | donor_gain | 0.9900 |
| 21:46291459:GACT:G | donor_gain | 0.9900 |
| 21:46291463:G:GG | donor_gain | 0.9900 |
| 21:46296156:TGACA:T | acceptor_loss | 0.9900 |
| 21:46296157:GACA:G | acceptor_loss | 0.9900 |
| 21:46296158:ACAG:A | acceptor_loss | 0.9900 |
| 21:46296159:CA:C | acceptor_loss | 0.9900 |
| 21:46296160:A:T | acceptor_loss | 0.9900 |
| 21:46296429:A:T | donor_gain | 0.9900 |
| 21:46287119:ATGAG:A | donor_loss | 0.9800 |
| 21:46287120:TGAG:T | donor_loss | 0.9800 |
| 21:46287121:GAGGT:G | donor_loss | 0.9800 |
| 21:46287122:AGGT:A | donor_loss | 0.9800 |
| 21:46287123:GGT:G | donor_loss | 0.9800 |
| 21:46287124:G:GA | donor_loss | 0.9800 |
| 21:46287125:T:A | donor_loss | 0.9800 |
| 21:46296160:A:AG | acceptor_gain | 0.9800 |
| 21:46296161:G:GG | acceptor_gain | 0.9800 |
| 21:46296229:AGGT:A | donor_loss | 0.9800 |
| 21:46296230:GGTAA:G | donor_loss | 0.9800 |
| 21:46296231:GT:G | donor_loss | 0.9800 |
| 21:46286857:A:AG | acceptor_gain | 0.9700 |
| 21:46286865:CCCAG:C | acceptor_loss | 0.9700 |
| 21:46286866:CCAGG:C | acceptor_loss | 0.9700 |
| 21:46286867:CAGGT:C | acceptor_loss | 0.9700 |
| 21:46286868:A:G | acceptor_loss | 0.9700 |
| 21:46286869:G:A | acceptor_loss | 0.9700 |
| 21:46286959:A:T | donor_gain | 0.9700 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000104642 (21:46287421 C>G,T), RS1000292264 (21:46303290 G>C), RS1000410052 (21:46300076 T>C), RS1000470171 (21:46298234 C>T), RS1000642637 (21:46303610 G>A), RS1000647481 (21:46290207 T>G), RS1000758402 (21:46294973 C>A,G), RS1000900191 (21:46304237 A>G), RS1000984634 (21:46295073 T>A,C), RS1001035102 (21:46288686 A>G), RS1001108108 (21:46288505 G>A), RS1001221277 (21:46312901 A>G), RS1001242868 (21:46302411 G>A,T), RS1001292247 (21:46298026 C>T), RS1001327541 (21:46308420 C>T)
Disease associations
OMIM: gene MIM:617461 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression, affects expression, affects cotreatment | 6 |
| methylmercuric chloride | increases expression, affects cotreatment | 2 |
| ginger extract | decreases reaction, increases abundance, increases expression | 1 |
| bisphenol A | increases expression, decreases reaction, increases abundance | 1 |
| beta-lapachone | decreases expression | 1 |
| sodium arsenite | affects cotreatment, decreases expression, increases abundance | 1 |
| manganese chloride | affects cotreatment, decreases expression, increases abundance | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression, decreases expression | 1 |
| ICG 001 | decreases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression, decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Arsenic | affects cotreatment, decreases expression, increases abundance | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Carbamazepine | affects expression | 1 |
| Estradiol | decreases expression | 1 |
| Gallic Acid | decreases expression | 1 |
| Manganese | increases abundance, affects cotreatment, decreases expression | 1 |
| Oils, Volatile | decreases reaction, increases abundance, increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
| Lactic Acid | decreases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_TY43 | HAP1 YBEY (-) 1 | Cancer cell line | Male |
| CVCL_TY44 | HAP1 YBEY (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.